Cargando…

Patients’ Perception on the Nutritional Therapy for Diabetic Nephropathy

Low protein diet (LPD) plays an important role in preventing the progression of diabetic nephropathy. However, it is a great burden to the patients. In this paper, we have studied the quality of life (QOL) in such patients. The study subjects were 59 patients (male 38, female 21) with type 2 diabete...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shide, Kenichiro, Takada, Yuka, Nakashima, Asuka, Tsuji, Hidemi, Wada, Keiko, Kuwabara, Akiko, Tanaka, Kiyoshi, Inagaki, Nobuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2014
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4011811/ https://www.ncbi.nlm.nih.gov/pubmed/24855408 http://dx.doi.org/10.4137/JCM.S13315

Ejemplares similares

Carbohydrate intake is associated with time spent in the euglycemic range in patients with type 1 diabetes
por: Ayano-Takahara, Shiho, et al.
Publicado: (2015)

Relationship of homocysteine and homocysteine‐related vitamins to bone mineral density in Japanese patients with type 2 diabetes
por: Yamada, Chizumi, et al.
Publicado: (2010)

A new Classification of Diabetic Nephropathy 2014: a report from Joint Committee on Diabetic Nephropathy
por: Haneda, Masakazu, et al.
Publicado: (2015)

Enteral supplementation with glutamine, fiber, and oligosaccharide modulates incretin and glucagon-like peptide-2 secretion
por: Joo, Erina, et al.
Publicado: (2015)

Year‐long effects of COVID‐19 restrictions on glycemic control and body composition in patients with glucose intolerance in Japan: A single‐center retrospective study
por: Tsukaguchi, Ryo, et al.
Publicado: (2022)

Effect of nutritional counseling and long term isomaltulose based liquid formula (MHN-01) intake on metabolic syndrome
por: Takeda, Eiji, et al.
Publicado: (2015)

Antiangiogenic Therapy for Diabetic Nephropathy
por: Tanabe, Katsuyuki, et al.
Publicado: (2017)

Efficacy of probiotics on the modulation of gut microbiota in the treatment of diabetic nephropathy
por: Nagase, Nozomi, et al.
Publicado: (2022)

Targeting β‐cell functions in therapy for type 2 diabetes
por: Fujimoto, Shimpei, et al.
Publicado: (2011)

Insufficiency of B vitamins with its possible clinical implications
por: Tanaka, Kiyoshi, et al.
Publicado: (2020)

Response to Letter: Insufficiency of B vitamins with its possible clinical implications
por: Tanaka, Kiyoshi, et al.
Publicado: (2021)

Vitamin K intake and health, consideration from the epidemiological studies
por: Kuwabara, Akiko, et al.
Publicado: (2021)

Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy
por: Kuwabara, Takashige, et al.
Publicado: (2013)

Tensin 2-deficient nephropathy: mechanosensitive nephropathy, genetic susceptibility
por: Sasaki, Hayato, et al.
Publicado: (2022)

Nutritional Intervention for a Patient with Diabetic Nephropathy
por: Kim, Hee Young
Publicado: (2014)

Deep Learning Could Diagnose Diabetic Nephropathy with Renal Pathological Immunofluorescent Images
por: Kitamura, Shinji, et al.
Publicado: (2020)

Advancements in transplantation therapy for diabetes: Pancreas, islet and stem cell
por: Nakamura, Toshihiro, et al.
Publicado: (2020)

Long-Term Effect of the Color Record Method in Self-Monitoring of Blood Glucose on Metabolic Parameters in Type 2 Diabetes: A 2-Year Follow-up of the Color IMPACT Study
por: Nishimura, Akiko, et al.
Publicado: (2018)

Nutrition Therapy for Liver Diseases Based on the Status of Nutritional Intake
por: Yasutake, Kenichiro, et al.
Publicado: (2012)

Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study
por: Nishimura, Akiko, et al.
Publicado: (2019)

The combination of dulaglutide and biguanide reduced bodyweight in Japanese patients with type 2 diabetes
por: Inagaki, Nobuya, et al.
Publicado: (2016)

iPSC technology‐based regenerative therapy for diabetes
por: Kondo, Yasushi, et al.
Publicado: (2017)

Circadian rhythms and diabetes
por: Kurose, Takeshi, et al.
Publicado: (2011)

Control of intestinal stem cell fate: A novel approach to treating diabetes
por: Yamane, Shunsuke, et al.
Publicado: (2015)

Pharmacokinetic and pharmacodynamic evaluation of linagliptin for the treatment of type 2 diabetes mellitus, with consideration of Asian patient populations
por: Ceriello, Antonio, et al.
Publicado: (2016)

Prognostic Nutritional Index as a Predictor of Diabetic Nephropathy Progression
por: Zhang, Junlin, et al.
Publicado: (2022)

Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action
por: Fujita, Yoshihito, et al.
Publicado: (2014)

Safety and effectiveness of dulaglutide 0.75 mg in Japanese patients with type 2 diabetes in real‐world clinical practice: 36 month post‐marketing observational study
por: Chin, Rina, et al.
Publicado: (2022)

Comparison of incretin immunoassays with or without plasma extraction: Incretin secretion in Japanese patients with type 2 diabetes
por: Yabe, Daisuke, et al.
Publicado: (2011)

Diabetic Nephropathy: A Comparison of the Clinical and Pathological Features between the CKD Risk Classification and the Classification of Diabetic Nephropathy 2014 in Japan
por: Furuichi, Kengo, et al.
Publicado: (2018)

Role of Reactive Oxygen Species in Glucose Metabolism Disorder in Diabetic Pancreatic β-Cells
por: Mukai, Eri, et al.
Publicado: (2022)

Cellular Senescence in Diabetes Mellitus: Distinct Senotherapeutic Strategies for Adipose Tissue and Pancreatic β Cells
por: Murakami, Takaaki, et al.
Publicado: (2022)

Long-term Effects of Mitiglinide in Japanese Diabetics Inadequately Controlled with DPP-4 Inhibitor or Biguanide Monotherapy
por: Kaku, Kohei, et al.
Publicado: (2014)

Apararenone in patients with diabetic nephropathy: results of a randomized, double-blind, placebo-controlled phase 2 dose–response study and open-label extension study
por: Wada, Takashi, et al.
Publicado: (2020)

The possible involvement of intestine-derived IgA(1): a case of IgA nephropathy associated with Crohn’s disease
por: Terasaka, Tomohiro, et al.
Publicado: (2016)

Initiating SGLT2 inhibitor therapy to improve renal outcomes for persons with diabetes eligible for an intensified glucose-lowering regimen: hypothetical intervention using parametric g-formula modeling
por: Takeuchi, Masato, et al.
Publicado: (2022)

Nivolumab-induced IgA nephropathy in a patient with advanced gastric cancer: A case report
por: Tanabe, Katsuyuki, et al.
Publicado: (2020)

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
por: Iijima, Hiroaki, et al.
Publicado: (2015)

Relationship between nutrition knowledge and dietary intake among primary school children in Japan: Combined effect of children's and their guardians' knowledge
por: Asakura, Keiko, et al.
Publicado: (2017)

Ablation of the N-type calcium channel ameliorates diabetic nephropathy with improved glycemic control and reduced blood pressure
por: Ohno, Shoko, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r3027o7eh4kc24pkeq8231f7t3